nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—superior mesenteric artery—liver cancer	0.198	0.914	CbGeAlD
Octreotide—SSTR1—liver—liver cancer	0.0141	0.0652	CbGeAlD
Octreotide—MPO—liver—liver cancer	0.00454	0.021	CbGeAlD
Octreotide—Decreased appetite—Sorafenib—liver cancer	0.00123	0.0024	CcSEcCtD
Octreotide—Thrombophlebitis—Epirubicin—liver cancer	0.00123	0.0024	CcSEcCtD
Octreotide—Bladder pain—Doxorubicin—liver cancer	0.00123	0.00239	CcSEcCtD
Octreotide—Mouth ulceration—Doxorubicin—liver cancer	0.00123	0.00239	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00122	0.00239	CcSEcCtD
Octreotide—Diabetes mellitus—Epirubicin—liver cancer	0.00122	0.00239	CcSEcCtD
Octreotide—Gastrointestinal disorder—Sorafenib—liver cancer	0.00122	0.00238	CcSEcCtD
Octreotide—Fatigue—Sorafenib—liver cancer	0.00122	0.00238	CcSEcCtD
Octreotide—Pain—Sorafenib—liver cancer	0.00121	0.00236	CcSEcCtD
Octreotide—Constipation—Sorafenib—liver cancer	0.00121	0.00236	CcSEcCtD
Octreotide—Cardiac failure congestive—Epirubicin—liver cancer	0.00117	0.00229	CcSEcCtD
Octreotide—Gastrointestinal pain—Sorafenib—liver cancer	0.00116	0.00226	CcSEcCtD
Octreotide—Phlebitis—Doxorubicin—liver cancer	0.00114	0.00223	CcSEcCtD
Octreotide—Hot flush—Epirubicin—liver cancer	0.00114	0.00222	CcSEcCtD
Octreotide—Thrombophlebitis—Doxorubicin—liver cancer	0.00114	0.00222	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00113	0.00221	CcSEcCtD
Octreotide—Diabetes mellitus—Doxorubicin—liver cancer	0.00113	0.00221	CcSEcCtD
Octreotide—Menopausal symptoms—Epirubicin—liver cancer	0.00113	0.0022	CcSEcCtD
Octreotide—Urticaria—Sorafenib—liver cancer	0.00112	0.00219	CcSEcCtD
Octreotide—Body temperature increased—Sorafenib—liver cancer	0.00112	0.00218	CcSEcCtD
Octreotide—Abdominal pain—Sorafenib—liver cancer	0.00112	0.00218	CcSEcCtD
Octreotide—Anaphylactoid reaction—Epirubicin—liver cancer	0.0011	0.00214	CcSEcCtD
Octreotide—Hypoglycaemia—Epirubicin—liver cancer	0.00109	0.00213	CcSEcCtD
Octreotide—Cardiac failure congestive—Doxorubicin—liver cancer	0.00108	0.00212	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00106	0.00208	CcSEcCtD
Octreotide—Osteoarthritis—Epirubicin—liver cancer	0.00106	0.00208	CcSEcCtD
Octreotide—Pain in extremity—Epirubicin—liver cancer	0.00106	0.00208	CcSEcCtD
Octreotide—Hot flush—Doxorubicin—liver cancer	0.00105	0.00205	CcSEcCtD
Octreotide—Menopausal symptoms—Doxorubicin—liver cancer	0.00104	0.00203	CcSEcCtD
Octreotide—Hypersensitivity—Sorafenib—liver cancer	0.00104	0.00203	CcSEcCtD
Octreotide—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00102	0.00198	CcSEcCtD
Octreotide—Asthenia—Sorafenib—liver cancer	0.00101	0.00198	CcSEcCtD
Octreotide—Hypoglycaemia—Doxorubicin—liver cancer	0.00101	0.00197	CcSEcCtD
Octreotide—Pruritus—Sorafenib—liver cancer	0.001	0.00195	CcSEcCtD
Octreotide—Dehydration—Epirubicin—liver cancer	0.000989	0.00193	CcSEcCtD
Octreotide—Osteoarthritis—Doxorubicin—liver cancer	0.000984	0.00192	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000984	0.00192	CcSEcCtD
Octreotide—Pain in extremity—Doxorubicin—liver cancer	0.000984	0.00192	CcSEcCtD
Octreotide—Dry skin—Epirubicin—liver cancer	0.000974	0.0019	CcSEcCtD
Octreotide—Abdominal pain upper—Epirubicin—liver cancer	0.000971	0.0019	CcSEcCtD
Octreotide—Diarrhoea—Sorafenib—liver cancer	0.000967	0.00189	CcSEcCtD
Octreotide—Nasopharyngitis—Epirubicin—liver cancer	0.000951	0.00186	CcSEcCtD
Octreotide—Gastritis—Epirubicin—liver cancer	0.000941	0.00184	CcSEcCtD
Octreotide—Muscular weakness—Epirubicin—liver cancer	0.000938	0.00183	CcSEcCtD
Octreotide—Dizziness—Sorafenib—liver cancer	0.000935	0.00182	CcSEcCtD
Octreotide—Abdominal distension—Epirubicin—liver cancer	0.000925	0.00181	CcSEcCtD
Octreotide—Asthma—Epirubicin—liver cancer	0.000919	0.00179	CcSEcCtD
Octreotide—Influenza—Epirubicin—liver cancer	0.000919	0.00179	CcSEcCtD
Octreotide—Dehydration—Doxorubicin—liver cancer	0.000915	0.00179	CcSEcCtD
Octreotide—Dry skin—Doxorubicin—liver cancer	0.000902	0.00176	CcSEcCtD
Octreotide—Pancreatitis—Epirubicin—liver cancer	0.000901	0.00176	CcSEcCtD
Octreotide—Vomiting—Sorafenib—liver cancer	0.000899	0.00175	CcSEcCtD
Octreotide—Abdominal pain upper—Doxorubicin—liver cancer	0.000898	0.00175	CcSEcCtD
Octreotide—Rash—Sorafenib—liver cancer	0.000891	0.00174	CcSEcCtD
Octreotide—Dermatitis—Sorafenib—liver cancer	0.000891	0.00174	CcSEcCtD
Octreotide—Headache—Sorafenib—liver cancer	0.000886	0.00173	CcSEcCtD
Octreotide—Bronchitis—Epirubicin—liver cancer	0.000884	0.00172	CcSEcCtD
Octreotide—Nasopharyngitis—Doxorubicin—liver cancer	0.00088	0.00172	CcSEcCtD
Octreotide—Gastritis—Doxorubicin—liver cancer	0.00087	0.0017	CcSEcCtD
Octreotide—Muscular weakness—Doxorubicin—liver cancer	0.000868	0.00169	CcSEcCtD
Octreotide—Dysuria—Epirubicin—liver cancer	0.000859	0.00168	CcSEcCtD
Octreotide—Abdominal distension—Doxorubicin—liver cancer	0.000856	0.00167	CcSEcCtD
Octreotide—Upper respiratory tract infection—Epirubicin—liver cancer	0.000854	0.00167	CcSEcCtD
Octreotide—Influenza—Doxorubicin—liver cancer	0.00085	0.00166	CcSEcCtD
Octreotide—Asthma—Doxorubicin—liver cancer	0.00085	0.00166	CcSEcCtD
Octreotide—Pollakiuria—Epirubicin—liver cancer	0.000849	0.00166	CcSEcCtD
Octreotide—Nausea—Sorafenib—liver cancer	0.00084	0.00164	CcSEcCtD
Octreotide—Weight increased—Epirubicin—liver cancer	0.000836	0.00163	CcSEcCtD
Octreotide—Pancreatitis—Doxorubicin—liver cancer	0.000833	0.00163	CcSEcCtD
Octreotide—Weight decreased—Epirubicin—liver cancer	0.000831	0.00162	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—liver cancer	0.000829	0.00162	CcSEcCtD
Octreotide—Pneumonia—Epirubicin—liver cancer	0.000824	0.00161	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—liver cancer	0.000819	0.0016	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—liver cancer	0.000818	0.0016	CcSEcCtD
Octreotide—Neuropathy peripheral—Epirubicin—liver cancer	0.000803	0.00157	CcSEcCtD
Octreotide—Jaundice—Epirubicin—liver cancer	0.000799	0.00156	CcSEcCtD
Octreotide—Conjunctivitis—Epirubicin—liver cancer	0.000796	0.00155	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—liver cancer	0.000796	0.00155	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—liver cancer	0.000795	0.00155	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00079	0.00154	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—liver cancer	0.000785	0.00153	CcSEcCtD
Octreotide—Haematuria—Epirubicin—liver cancer	0.000781	0.00152	CcSEcCtD
Octreotide—Hepatobiliary disease—Epirubicin—liver cancer	0.000775	0.00151	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—liver cancer	0.000774	0.00151	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—liver cancer	0.000773	0.00151	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—liver cancer	0.000769	0.0015	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—liver cancer	0.000769	0.0015	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—liver cancer	0.000767	0.0015	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—liver cancer	0.000762	0.00149	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—liver cancer	0.000758	0.00148	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—liver cancer	0.000749	0.00146	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—liver cancer	0.000743	0.00145	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—liver cancer	0.000739	0.00144	CcSEcCtD
Octreotide—Rhinitis—Epirubicin—liver cancer	0.000737	0.00144	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—liver cancer	0.000737	0.00144	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—liver cancer	0.000737	0.00144	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—liver cancer	0.000735	0.00144	CcSEcCtD
Octreotide—Hypoaesthesia—Epirubicin—liver cancer	0.000732	0.00143	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—liver cancer	0.00073	0.00142	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—liver cancer	0.000724	0.00141	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—liver cancer	0.000723	0.00141	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—liver cancer	0.000717	0.0014	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—liver cancer	0.000715	0.0014	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—liver cancer	0.000711	0.00139	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—liver cancer	0.000709	0.00138	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—liver cancer	0.000693	0.00135	CcSEcCtD
Octreotide—Tinnitus—Epirubicin—liver cancer	0.000686	0.00134	CcSEcCtD
Octreotide—Flushing—Epirubicin—liver cancer	0.000683	0.00133	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—liver cancer	0.000683	0.00133	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—liver cancer	0.000682	0.00133	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—liver cancer	0.00068	0.00133	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—liver cancer	0.000677	0.00132	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—liver cancer	0.000675	0.00132	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—liver cancer	0.00067	0.00131	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—liver cancer	0.000664	0.0013	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—liver cancer	0.000657	0.00128	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—liver cancer	0.000656	0.00128	CcSEcCtD
Octreotide—Alopecia—Epirubicin—liver cancer	0.00065	0.00127	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—liver cancer	0.000644	0.00126	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—liver cancer	0.00064	0.00125	CcSEcCtD
Octreotide—Erythema—Epirubicin—liver cancer	0.00064	0.00125	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—liver cancer	0.000634	0.00124	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—liver cancer	0.000632	0.00123	CcSEcCtD
Octreotide—Flushing—Doxorubicin—liver cancer	0.000632	0.00123	CcSEcCtD
Octreotide—Flatulence—Epirubicin—liver cancer	0.000631	0.00123	CcSEcCtD
Octreotide—Tension—Epirubicin—liver cancer	0.000628	0.00123	CcSEcCtD
Octreotide—Nervousness—Epirubicin—liver cancer	0.000622	0.00121	CcSEcCtD
Octreotide—Back pain—Epirubicin—liver cancer	0.000619	0.00121	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—liver cancer	0.000615	0.0012	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—liver cancer	0.000615	0.0012	CcSEcCtD
Octreotide—Arrhythmia—Doxorubicin—liver cancer	0.000608	0.00119	CcSEcCtD
Octreotide—Vision blurred—Epirubicin—liver cancer	0.000603	0.00118	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—liver cancer	0.000601	0.00117	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—liver cancer	0.000596	0.00116	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—liver cancer	0.000594	0.00116	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—liver cancer	0.000592	0.00116	CcSEcCtD
Octreotide—Erythema—Doxorubicin—liver cancer	0.000592	0.00116	CcSEcCtD
Octreotide—Anaemia—Epirubicin—liver cancer	0.000592	0.00115	CcSEcCtD
Octreotide—Agitation—Epirubicin—liver cancer	0.000588	0.00115	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—liver cancer	0.000584	0.00114	CcSEcCtD
Octreotide—Tension—Doxorubicin—liver cancer	0.000581	0.00113	CcSEcCtD
Octreotide—Malaise—Epirubicin—liver cancer	0.000577	0.00113	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—liver cancer	0.000575	0.00112	CcSEcCtD
Octreotide—Vertigo—Epirubicin—liver cancer	0.000575	0.00112	CcSEcCtD
Octreotide—Syncope—Epirubicin—liver cancer	0.000574	0.00112	CcSEcCtD
Octreotide—Back pain—Doxorubicin—liver cancer	0.000573	0.00112	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—liver cancer	0.00057	0.00111	CcSEcCtD
Octreotide—Palpitations—Epirubicin—liver cancer	0.000566	0.0011	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—liver cancer	0.000563	0.0011	CcSEcCtD
Octreotide—Cough—Epirubicin—liver cancer	0.000559	0.00109	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—liver cancer	0.000558	0.00109	CcSEcCtD
Octreotide—Convulsion—Epirubicin—liver cancer	0.000555	0.00108	CcSEcCtD
Octreotide—Hypertension—Epirubicin—liver cancer	0.000553	0.00108	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—liver cancer	0.00055	0.00107	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—liver cancer	0.000547	0.00107	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—liver cancer	0.000545	0.00106	CcSEcCtD
Octreotide—Myalgia—Epirubicin—liver cancer	0.000545	0.00106	CcSEcCtD
Octreotide—Chest pain—Epirubicin—liver cancer	0.000545	0.00106	CcSEcCtD
Octreotide—Agitation—Doxorubicin—liver cancer	0.000544	0.00106	CcSEcCtD
Octreotide—Anxiety—Epirubicin—liver cancer	0.000543	0.00106	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000541	0.00106	CcSEcCtD
Octreotide—Discomfort—Epirubicin—liver cancer	0.000538	0.00105	CcSEcCtD
Octreotide—Malaise—Doxorubicin—liver cancer	0.000534	0.00104	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—liver cancer	0.000533	0.00104	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—liver cancer	0.000532	0.00104	CcSEcCtD
Octreotide—Syncope—Doxorubicin—liver cancer	0.000531	0.00104	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—liver cancer	0.000523	0.00102	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—liver cancer	0.000522	0.00102	CcSEcCtD
Octreotide—Oedema—Epirubicin—liver cancer	0.000522	0.00102	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—liver cancer	0.000521	0.00102	CcSEcCtD
Octreotide—Infection—Epirubicin—liver cancer	0.000519	0.00101	CcSEcCtD
Octreotide—Cough—Doxorubicin—liver cancer	0.000517	0.00101	CcSEcCtD
Octreotide—Shock—Epirubicin—liver cancer	0.000514	0.001	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—liver cancer	0.000513	0.001	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—liver cancer	0.000512	0.001	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—liver cancer	0.000512	0.000999	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—liver cancer	0.000511	0.000998	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—liver cancer	0.00051	0.000995	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—liver cancer	0.000507	0.000991	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—liver cancer	0.000505	0.000986	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—liver cancer	0.000504	0.000984	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—liver cancer	0.000504	0.000984	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—liver cancer	0.000504	0.000984	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—liver cancer	0.000503	0.000981	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000501	0.000978	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—liver cancer	0.000498	0.000973	CcSEcCtD
Octreotide—Anorexia—Epirubicin—liver cancer	0.000498	0.000972	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—liver cancer	0.000493	0.000963	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—liver cancer	0.000483	0.000944	CcSEcCtD
Octreotide—Oedema—Doxorubicin—liver cancer	0.000483	0.000944	CcSEcCtD
Octreotide—Infection—Doxorubicin—liver cancer	0.00048	0.000937	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000476	0.000929	CcSEcCtD
Octreotide—Shock—Doxorubicin—liver cancer	0.000476	0.000928	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—liver cancer	0.000474	0.000925	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—liver cancer	0.000473	0.000924	CcSEcCtD
Octreotide—Insomnia—Epirubicin—liver cancer	0.000473	0.000922	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—liver cancer	0.000472	0.000921	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—liver cancer	0.00047	0.000917	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—liver cancer	0.000469	0.000916	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—liver cancer	0.000467	0.000912	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—liver cancer	0.000466	0.000909	CcSEcCtD
Octreotide—Somnolence—Epirubicin—liver cancer	0.000464	0.000907	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—liver cancer	0.000461	0.000899	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—liver cancer	0.00046	0.000898	CcSEcCtD
Octreotide—Decreased appetite—Epirubicin—liver cancer	0.000454	0.000887	CcSEcCtD
Octreotide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000451	0.00088	CcSEcCtD
Octreotide—Fatigue—Epirubicin—liver cancer	0.00045	0.000879	CcSEcCtD
Octreotide—Pain—Epirubicin—liver cancer	0.000447	0.000872	CcSEcCtD
Octreotide—Constipation—Epirubicin—liver cancer	0.000447	0.000872	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00044	0.00086	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—liver cancer	0.000437	0.000853	CcSEcCtD
Octreotide—Paraesthesia—Doxorubicin—liver cancer	0.000434	0.000847	CcSEcCtD
Octreotide—Dyspnoea—Doxorubicin—liver cancer	0.000431	0.000841	CcSEcCtD
Octreotide—Feeling abnormal—Epirubicin—liver cancer	0.000431	0.00084	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—liver cancer	0.00043	0.000839	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—liver cancer	0.000427	0.000834	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—liver cancer	0.000426	0.000831	CcSEcCtD
Octreotide—Decreased appetite—Doxorubicin—liver cancer	0.00042	0.00082	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000417	0.000815	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—liver cancer	0.000417	0.000814	CcSEcCtD
Octreotide—Urticaria—Epirubicin—liver cancer	0.000415	0.00081	CcSEcCtD
Octreotide—Constipation—Doxorubicin—liver cancer	0.000413	0.000807	CcSEcCtD
Octreotide—Pain—Doxorubicin—liver cancer	0.000413	0.000807	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—liver cancer	0.000413	0.000806	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—liver cancer	0.000413	0.000806	CcSEcCtD
Octreotide—Feeling abnormal—Doxorubicin—liver cancer	0.000398	0.000778	CcSEcCtD
Octreotide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000395	0.000772	CcSEcCtD
Octreotide—Hypersensitivity—Epirubicin—liver cancer	0.000385	0.000751	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—liver cancer	0.000384	0.00075	CcSEcCtD
Octreotide—Abdominal pain—Doxorubicin—liver cancer	0.000382	0.000746	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—liver cancer	0.000382	0.000746	CcSEcCtD
Octreotide—Asthenia—Epirubicin—liver cancer	0.000375	0.000732	CcSEcCtD
Octreotide—Pruritus—Epirubicin—liver cancer	0.00037	0.000722	CcSEcCtD
Octreotide—Diarrhoea—Epirubicin—liver cancer	0.000357	0.000698	CcSEcCtD
Octreotide—Hypersensitivity—Doxorubicin—liver cancer	0.000356	0.000695	CcSEcCtD
Octreotide—Asthenia—Doxorubicin—liver cancer	0.000347	0.000677	CcSEcCtD
Octreotide—Dizziness—Epirubicin—liver cancer	0.000346	0.000674	CcSEcCtD
Octreotide—Pruritus—Doxorubicin—liver cancer	0.000342	0.000668	CcSEcCtD
Octreotide—Vomiting—Epirubicin—liver cancer	0.000332	0.000648	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—liver cancer	0.000331	0.000646	CcSEcCtD
Octreotide—Rash—Epirubicin—liver cancer	0.000329	0.000643	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—liver cancer	0.000329	0.000642	CcSEcCtD
Octreotide—Headache—Epirubicin—liver cancer	0.000327	0.000639	CcSEcCtD
Octreotide—Dizziness—Doxorubicin—liver cancer	0.00032	0.000624	CcSEcCtD
Octreotide—Nausea—Epirubicin—liver cancer	0.00031	0.000606	CcSEcCtD
Octreotide—Vomiting—Doxorubicin—liver cancer	0.000307	0.0006	CcSEcCtD
Octreotide—Rash—Doxorubicin—liver cancer	0.000305	0.000595	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—liver cancer	0.000305	0.000594	CcSEcCtD
Octreotide—Headache—Doxorubicin—liver cancer	0.000303	0.000591	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—PIK3CG—liver cancer	0.000298	0.0011	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADAM17—liver cancer	0.000298	0.0011	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CG—liver cancer	0.000291	0.00107	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2—liver cancer	0.000289	0.00106	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CD—liver cancer	0.000289	0.00106	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TERT—liver cancer	0.000288	0.00106	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—liver cancer	0.000287	0.000561	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—F2—liver cancer	0.000281	0.00103	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PSMA4—liver cancer	0.00028	0.00103	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PSMD10—liver cancer	0.00028	0.00103	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCE—liver cancer	0.000276	0.00102	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—F2—liver cancer	0.000276	0.00102	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CD—liver cancer	0.000273	0.00101	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CG—liver cancer	0.000269	0.000989	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCE—liver cancer	0.000265	0.000976	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CG—liver cancer	0.000264	0.000974	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KDR—liver cancer	0.000263	0.000969	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CB—liver cancer	0.000262	0.000966	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CD—liver cancer	0.000262	0.000965	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF2—liver cancer	0.000262	0.000965	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK14—liver cancer	0.000261	0.000962	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ESR1—liver cancer	0.000256	0.000944	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CD—liver cancer	0.000256	0.000942	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—F2—liver cancer	0.000255	0.000939	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—F2—liver cancer	0.000253	0.000933	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CB—liver cancer	0.000252	0.000926	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF2—liver cancer	0.000251	0.000925	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CSF2—liver cancer	0.000245	0.000901	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—RAF1—liver cancer	0.000244	0.000899	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CG—liver cancer	0.000244	0.000898	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—liver cancer	0.000242	0.000893	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APC—liver cancer	0.000242	0.000893	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—H2AFX—liver cancer	0.000241	0.000888	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—liver cancer	0.000241	0.000887	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CB—liver cancer	0.000238	0.000877	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CD—liver cancer	0.000236	0.00087	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCE—liver cancer	0.000235	0.000866	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CSF2—liver cancer	0.000234	0.000864	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RAF1—liver cancer	0.000234	0.000862	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CD—liver cancer	0.000232	0.000856	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—H2AFX—liver cancer	0.000231	0.000851	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—liver cancer	0.000231	0.000851	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CB—liver cancer	0.000228	0.000841	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—BRAF—liver cancer	0.000228	0.000839	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CB—liver cancer	0.000223	0.000821	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF2—liver cancer	0.000223	0.00082	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2—liver cancer	0.000219	0.000806	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TERT—liver cancer	0.000218	0.000803	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCE—liver cancer	0.000217	0.000799	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CD—liver cancer	0.000214	0.00079	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CD—liver cancer	0.000213	0.000785	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—liver cancer	0.000211	0.000777	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—liver cancer	0.000211	0.000776	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—liver cancer	0.00021	0.000772	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TERT—liver cancer	0.000209	0.00077	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—liver cancer	0.000209	0.000768	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CSF2—liver cancer	0.000208	0.000766	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RAF1—liver cancer	0.000207	0.000764	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CB—liver cancer	0.000206	0.000758	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF2—liver cancer	0.000206	0.000757	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—H2AFX—liver cancer	0.000205	0.000755	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—liver cancer	0.000205	0.000754	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—liver cancer	0.000203	0.000746	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—liver cancer	0.000199	0.000734	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK14—liver cancer	0.000198	0.000729	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—liver cancer	0.000194	0.000716	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CSF2—liver cancer	0.000192	0.000707	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—F2—liver cancer	0.000192	0.000707	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—liver cancer	0.000192	0.000706	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RAF1—liver cancer	0.000191	0.000705	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—liver cancer	0.000191	0.000704	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAF1—liver cancer	0.00019	0.0007	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK14—liver cancer	0.00019	0.000699	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—H2AFX—liver cancer	0.000189	0.000697	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—liver cancer	0.000189	0.000696	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—liver cancer	0.000187	0.000688	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—liver cancer	0.000186	0.000686	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—liver cancer	0.000186	0.000685	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—liver cancer	0.000186	0.000684	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—liver cancer	0.000186	0.000684	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—liver cancer	0.000185	0.000683	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—F2—liver cancer	0.000184	0.000678	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—liver cancer	0.000184	0.000676	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—liver cancer	0.000184	0.000676	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—liver cancer	0.000177	0.000653	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—liver cancer	0.000176	0.000648	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—liver cancer	0.000176	0.000648	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—liver cancer	0.000174	0.000642	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—liver cancer	0.000173	0.000636	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—liver cancer	0.000172	0.000635	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—liver cancer	0.000172	0.000632	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—liver cancer	0.000171	0.00063	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—liver cancer	0.000171	0.000629	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—liver cancer	0.000171	0.000628	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—liver cancer	0.00017	0.000625	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—liver cancer	0.00017	0.000624	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK14—liver cancer	0.000168	0.00062	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—liver cancer	0.000166	0.000612	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUN—liver cancer	0.000166	0.000611	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—liver cancer	0.000166	0.00061	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—liver cancer	0.000165	0.000608	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—liver cancer	0.000165	0.000606	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—liver cancer	0.000163	0.000601	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—liver cancer	0.000161	0.000595	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—liver cancer	0.000161	0.000594	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1A—liver cancer	0.000161	0.000592	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—liver cancer	0.00016	0.000589	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—liver cancer	0.00016	0.000588	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—liver cancer	0.000158	0.000582	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK8—liver cancer	0.000157	0.000578	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—liver cancer	0.000157	0.000577	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—liver cancer	0.000156	0.000576	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—liver cancer	0.000156	0.000575	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—liver cancer	0.000156	0.000575	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK14—liver cancer	0.000155	0.000572	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—liver cancer	0.000155	0.00057	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000153	0.000565	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—liver cancer	0.000153	0.000564	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—liver cancer	0.000152	0.000561	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—liver cancer	0.000152	0.000558	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—liver cancer	0.000151	0.000555	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—liver cancer	0.000147	0.000541	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—liver cancer	0.000145	0.000535	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—liver cancer	0.000145	0.000534	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—liver cancer	0.000144	0.000531	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—liver cancer	0.000144	0.000531	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—liver cancer	0.000144	0.000531	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—liver cancer	0.000144	0.000529	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—liver cancer	0.000141	0.000518	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—liver cancer	0.000141	0.000518	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—liver cancer	0.000139	0.000513	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAF1—liver cancer	0.000138	0.000509	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—liver cancer	0.000137	0.000506	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—liver cancer	0.000136	0.000501	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—liver cancer	0.000136	0.0005	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—liver cancer	0.000135	0.000499	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—liver cancer	0.000135	0.000497	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—liver cancer	0.000135	0.000497	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—liver cancer	0.000134	0.000495	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—liver cancer	0.000134	0.000495	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—liver cancer	0.000133	0.000491	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—liver cancer	0.000133	0.00049	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—liver cancer	0.000132	0.000486	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—liver cancer	0.000131	0.000481	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—liver cancer	0.000129	0.000477	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—liver cancer	0.000129	0.000476	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—liver cancer	0.000129	0.000474	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—liver cancer	0.000129	0.000474	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—liver cancer	0.000127	0.000467	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—liver cancer	0.000127	0.000466	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—liver cancer	0.000126	0.000464	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUN—liver cancer	0.000126	0.000463	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—liver cancer	0.000125	0.000462	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—liver cancer	0.000125	0.000461	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—liver cancer	0.000125	0.000461	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—liver cancer	0.000125	0.000459	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—liver cancer	0.000124	0.000457	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—liver cancer	0.000124	0.000457	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—liver cancer	0.000124	0.000456	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—liver cancer	0.000123	0.000455	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—liver cancer	0.000123	0.000454	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—liver cancer	0.000123	0.000454	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—liver cancer	0.000123	0.000451	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—liver cancer	0.000122	0.00045	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1A—liver cancer	0.000122	0.000449	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—liver cancer	0.000121	0.000445	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JUN—liver cancer	0.000121	0.000444	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—liver cancer	0.00012	0.000441	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—liver cancer	0.00012	0.000441	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—liver cancer	0.00012	0.000441	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK8—liver cancer	0.000119	0.000438	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—liver cancer	0.000119	0.000437	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—liver cancer	0.000117	0.000432	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1A—liver cancer	0.000117	0.00043	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—liver cancer	0.000114	0.000421	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK8—liver cancer	0.000114	0.00042	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—liver cancer	0.000114	0.00042	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—liver cancer	0.000114	0.000419	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—liver cancer	0.000113	0.000417	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—liver cancer	0.000113	0.000417	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—liver cancer	0.000112	0.000414	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—liver cancer	0.000111	0.000409	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—liver cancer	0.00011	0.000407	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—liver cancer	0.00011	0.000407	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—liver cancer	0.00011	0.000405	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—liver cancer	0.00011	0.000405	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—liver cancer	0.00011	0.000405	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—liver cancer	0.00011	0.000403	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—liver cancer	0.000109	0.000403	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—liver cancer	0.000109	0.000401	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—liver cancer	0.000107	0.000395	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JUN—liver cancer	0.000107	0.000394	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—liver cancer	0.000106	0.000391	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—liver cancer	0.000105	0.000388	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—liver cancer	0.000105	0.000388	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—liver cancer	0.000105	0.000386	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—liver cancer	0.000104	0.000384	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—liver cancer	0.000104	0.000383	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1A—liver cancer	0.000104	0.000382	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—liver cancer	0.000104	0.000382	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—liver cancer	0.000103	0.000378	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—liver cancer	0.000102	0.000374	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—liver cancer	0.000101	0.000374	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK8—liver cancer	0.000101	0.000373	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—liver cancer	0.000101	0.000372	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—liver cancer	0.000101	0.000372	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—liver cancer	0.000101	0.000372	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—liver cancer	0.000101	0.000371	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—liver cancer	0.0001	0.000369	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—liver cancer	9.89e-05	0.000364	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JUN—liver cancer	9.87e-05	0.000363	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—liver cancer	9.79e-05	0.000361	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—liver cancer	9.69e-05	0.000357	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—liver cancer	9.67e-05	0.000356	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—liver cancer	9.6e-05	0.000353	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1A—liver cancer	9.56e-05	0.000352	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—liver cancer	9.34e-05	0.000344	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—liver cancer	9.34e-05	0.000344	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK8—liver cancer	9.33e-05	0.000344	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—liver cancer	9.31e-05	0.000343	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—liver cancer	9.25e-05	0.000341	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—liver cancer	9.25e-05	0.000341	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—liver cancer	8.95e-05	0.00033	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—liver cancer	8.62e-05	0.000317	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—liver cancer	8.59e-05	0.000316	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—liver cancer	8.58e-05	0.000316	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—liver cancer	8.57e-05	0.000316	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—liver cancer	8.53e-05	0.000314	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—liver cancer	8.3e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—liver cancer	8.22e-05	0.000303	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—liver cancer	7.96e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—liver cancer	7.94e-05	0.000292	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—liver cancer	7.94e-05	0.000292	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—liver cancer	7.93e-05	0.000292	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—liver cancer	7.91e-05	0.000291	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—liver cancer	7.61e-05	0.00028	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—liver cancer	7.6e-05	0.00028	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—liver cancer	7.33e-05	0.00027	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—liver cancer	7.29e-05	0.000269	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—liver cancer	7.28e-05	0.000268	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—liver cancer	7.06e-05	0.00026	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—liver cancer	7.01e-05	0.000258	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—liver cancer	6.75e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—liver cancer	6.73e-05	0.000248	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—liver cancer	6.72e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—liver cancer	6.51e-05	0.00024	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—liver cancer	6.46e-05	0.000238	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—liver cancer	6.23e-05	0.000229	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—liver cancer	5.96e-05	0.00022	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—liver cancer	5.96e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—liver cancer	5.5e-05	0.000203	CbGpPWpGaD
